Navigation Links
Positive Clinical Data for TASQ - Active Biotech's Novel Treatment,of Prostate Cancer

LUND, Sweden, March, 9, 2007-Active Biotech (ACTI.ST), today announced new positive clinical data from the Phase Ib study of TASQ, for the treatment of prostate cancer.

By step-wise dose escalation, a safe dose of 1 mg/day of TASQ was achieved, which corresponds to a doubling of the previously reported maximum tolerated dose (MTD) level of 0.5 mg/day. This means that a step-wise intra-patient dose-escalation enables a dose of 1 mg/day to be administered in future clinical trials.

"These new results confirm and reinforce earlier results obtained at a lower dose level. We now have a very complete data set that constitute a solid base to move into Phase II clinical trials", said Sven Andréasson, President and CEO of Active Biotech.

The ongoing 10-week study comprises patients with so called hormone-refractory prostate cancer. This is an advanced stage of prostate cancer where the tumor cells no longer respond to hormone treatment. All patients entering the study had rising serum levels of Prostate Specific Antigen (PSA), which is a surrogate marker for tumor progression.

PSA measurements were recorded and PSA velocity (PSAV) was calculated after 28 days of treatment. Five out of six patients had a >50% decrease in PSA velocity compared to prior treatment. Three of these five patients exhibited a decrease in absolute PSA levels.

The study is being performed at the urological clinics at the University Hospitals in Lund, Malmö and Uppsala, Sweden.

The objective of the TASQ project is to develop a pharmaceutical product that can be administered orally for the long-term treatment of prostate cancer. Phase II studies are scheduled to start during 2007. The Medical Products Agency has approved on the new MTD to be used in the continued clinical program of TASQ.

The pharmaceutical market for prostate cancer is estimated at more than USD 3 billion a year. Prostat
'"/>




Page: 1 2

Related medicine technology :

1. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
2. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Protox Announces Positive Clinical Data from Prostate Cancer Study
5. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
6. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
7. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
8. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Chi-Med Announces Positive Phase II Proof-of-Concept Data for HMPL-004 in Ulcerative Colitis
Post Your Comments:
(Date:8/21/2014)... 21, 2014  Vermillion, Inc. (NASDAQ: VRML ... and women,s health, has appointed Holly B. Bauzon ... Ms. Bauzon has a proven track record ... for laboratory services companies. She has more than 20 ... where she held the position of Director, Lab Services ...
(Date:8/21/2014)... , Aug. 21, 2014  eRelevance Corporation ( ... announced today that it has completed integration with ... for Plastic Surgery and Dermatology practices. ... value to healthcare practices using Nextech," stated ... Corporation. "Using information from the EMR we are ...
(Date:8/21/2014)... YORK , Aug. 21, 2014  Publicis Groupe ... Shannon Hartley , Managing Partner and Healthcare Industry Group ... PharmaVoice 100, which recognizes the most inspiring people in ... are leaders in research and development, marketing, technology, creativity, ... agency in 2006 as a partner in its leading ...
Breaking Medicine Technology:Vermillion Appoints Holly B. Bauzon as VP of Sales and Managed Markets 2eRelevance Corporation Integrates with Nextech Electronic Medical Records 2Shannon Hartley Shines in PharmaVOICE 100 2
... BRIDGEWATER, N.J., Oct. 8 Advanced Health Media, LLC ... marketing services and related technology for the pharmaceutical and ... industry leader in speaker bureau management, supplying automation and ... and coordinating promotional events for more than 200 brands. ...
... Oct. 8 Cancer treatments are on track to become ... to overall drug spending hit five percent for the first ... Health Solutions, Inc. (NYSE: MHS). Oncology specialty drug spending ... conditions and multiple sclerosis as a specialty drug growth driver. ...
Cached Medicine Technology:Advanced Health Media Announces Acquisition of Ephikacy, LLC 2Advanced Health Media Announces Acquisition of Ephikacy, LLC 3Cancer Drugs Emerging as Top Driver of Specialty Drug Spending 2Cancer Drugs Emerging as Top Driver of Specialty Drug Spending 3Cancer Drugs Emerging as Top Driver of Specialty Drug Spending 4
(Date:8/22/2014)... 2014 Aid in Recovery, a full ... today regarding a recent bill introduced in ... a current legislator and retired police general. In House ... related offenders, rather than imprisonment. Aid in Recovery points ... solution for the drug addiction epidemic. , The bill, ...
(Date:8/21/2014)... August 22, 2014 Os-Monitor.com, an ... unveiled its new employee monitoring software collection ( ... has also announced that all these high end ... , With the tendency of improving productivity, the ... efficiency than before. Thus, employee and network monitoring ...
(Date:8/21/2014)... (PRWEB) August 22, 2014 Recently, Top10BestSEOHosting.com ... that HostMonster is one of the most ... hosting products. , There has been a boom in ... resulted in an increase in the number of web ... at very affordable prices. , HostMonster has been providing ...
(Date:8/21/2014)... Recently, Skmen.com, a distinguished garment supplier, has updated ... girls’ casual dresses . From today until August 31, all ... off) when they are shopping at the company’s online store. ... according to the newest quality standards; they are guaranteed to ... dresses, worldwide ladies can also access the other cheap items ...
(Date:8/21/2014)... 2014 AVEC Health Solutions, LLC, ... addition of Kerry Gillespie as Chief Executive Officer. ... experience, Gillespie brings an extremely robust background to ... positions with prominent industry leading organizations across the ... of Triad Isotopes, Inc. a private nuclear pharmaceutical ...
Breaking Medicine News(10 mins):Health News:Proposed Legislature in the Philippines Highlights the Need for Rehabilitation, Not Incarceration, for Drug Users, Says Aid in Recovery 2Health News:Proposed Legislature in the Philippines Highlights the Need for Rehabilitation, Not Incarceration, for Drug Users, Says Aid in Recovery 3Health News:New Employee Monitoring Software Collection Unveiled By Os-Monitor.com 2Health News:Best SEO Hosting Suppliers in the Global Market Recommended by Top10BestSEOHosting.com 2Health News:Charming Girls’ Casual Dresses Now Released by Distinguished Garment Company Skmen.com 2Health News:Kerry Gillespie Appointed as Chief Executive Officer of AVEC Health Solutions 2
... HealthDay Reporter , TUESDAY, Dec. 7 (HealthDay News) ... more likely to take up smoking than teens whose parents ... research. , In fact, the study authors estimated that ... movies, their risk of starting to smoke could drop two ...
... News) -- Teens who have health problems have fewer friends ... than they actually are, new research shows. U.S. researchers ... a 1994-1996 survey that asked them about their health and ... health as "excellent" or "very good." The rest of the ...
... ER? A group of computer engineers at Vanderbilt ... available to create robot assistants that can perform effectively ... specialists in emergency medicine at Vanderbilt University Medical Center ... groups have formed an interdisciplinary team to explore the ...
... The John Theurer Cancer Center at Hackensack University Medical ... annual meeting of the American Society of Hematology (ASH) ... ASH meeting is the world,s leading scientific gathering of ... the 40 abstracts from the John Theurer Cancer Center ...
... School of Hygiene & Tropical Medicine (LSHTM) has contributed to ... the occurrence of several common cancers. The study is published ... started and carried out by Professor Peter Rothwell in Oxford, ... of aspirin. These have been primarily concerned with reducing heart ...
... A study published in the December issue of The ... tomography/computed tomography (PET/CT) scans as a potentially useful tool ... with radiofrequency ablation (RFA). RFA, which uses localized thermal ... an alternative treatment for patients unable to undergo surgery ...
Cached Medicine News:Health News:Watching R-rated Movies Ups Odds of Teens Smoking 2Health News:Watching R-rated Movies Ups Odds of Teens Smoking 3Health News:Teens' Poor Health Linked to Fewer Friends 2Health News:Developing robots for the hospital emergency room 2Health News:Developing robots for the hospital emergency room 3Health News:John Theurer Cancer Center presents studies on promising therapies for aggressive blood cancers 2Health News:John Theurer Cancer Center presents studies on promising therapies for aggressive blood cancers 3Health News:John Theurer Cancer Center presents studies on promising therapies for aggressive blood cancers 4Health News:John Theurer Cancer Center presents studies on promising therapies for aggressive blood cancers 5Health News:John Theurer Cancer Center presents studies on promising therapies for aggressive blood cancers 6Health News:John Theurer Cancer Center presents studies on promising therapies for aggressive blood cancers 7Health News:Low-dose aspirin reduces death rates from range of cancers by between 20 and 30 percent 2Health News:Fewer guessing games for lung cancer patients 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: